Open AccessComparison of prostate cancer detection rates between magnetic resonance imaging-targeted biopsy and transrectal ultrasound-guided biopsy according to Prostate Imaging Reporting and Data System in patients with PSA ≥4 ng/mL: a systematic review and meta-analysis
Author(s) -
Kai Zhu,
Zhiqiang Qin,
Jianxin Xue,
Chenkui Miao,
Ye Tian,
Shouyong Liu,
Shenhao Zhu,
Qi Gu,
Chao Hou,
Aiming Xu,
Jie Yang,
Zengjun Wang
Publication year - 2019
Publication title -
translational andrology and urology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.721
H-Index - 27
eISSN - 2223-4691
pISSN - 2223-4683
DOI - 10.21037/tau.2019.12.03
Subject(s) - medicine , prostate cancer , prostate , rectal examination , prostate biopsy , biopsy , magnetic resonance imaging , radiology , ultrasound , odds ratio , meta analysis , cancer
Previous studies have investigated magnetic resonance imaging-targeted biopsy (MRI-TBx) on the detection for prostate cancer (PCa). Prostate Imaging Reporting and Data System (PI-RADS), as a standardized MRI reporting system, has widely been used in the management of PCa. However, basing the PI-RADS score, the comparability between MRI-TBx and transrectal ultrasound-guided biopsy (TRUS-Bx) in diagnosing PCa remained inconsistent or even controversial. Thus, this systematic meta-analysis aimed to assess the value of PI-RADS in sifting better prostate biopsy method.